Last quarter (Q4 2024), Tiziana Life Sciences's total revenue was £0.00, a decrease of ― from the same quarter last year. In Q4, Tiziana Life Sciences's net income was £-7.21M. See Tiziana Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	£ 0.00	£ 0.00	£ 0.00	£ 0.00	£ 0.00
Gross Profit	£ 0.00	£ 0.00	£ 0.00	£ 0.00	£ 0.00
Operating Expenses	£ 15.79M	£ 17.98M	£ 14.59M	£ 27.37M	£ 28.03M
Depreciation and Amortization	£ 124.00K	£ 96.00K	£ 51.00K	£ 141.00K	£ 89.76K
EBITDA	£ -16.62M	£ -17.14M	£ -15.34M	£ -26.34M	£ -27.93M
Operating Income	£ -15.79M	£ -17.98M	£ -14.59M	£ -27.37M	£ -28.03M
Other Income/Expenses	£ -952.00K	£ 742.00K	£ -811.00K	£ 717.00K	£ -312.00K
Pretax Income	£ -16.75M	£ -17.24M	£ -15.40M	£ -26.66M	£ -28.34M
Net Income	£ -11.86M	£ -17.69M	£ -15.40M	£ -23.42M	£ -26.13M
Per Share Metrics
Basic EPS	£ -0.22	£ -0.34	£ -0.30	£ -0.48	£ -0.54
Diluted EPS	£ -0.22	£ -0.34	£ -0.30	£ -0.48	£ -0.54
Weighted Average Shares Outstanding	53.34M	50.76M	50.76M	48.97M	48.65M
Weighted Average Shares Outstanding (Diluted)	53.34M	50.76M	50.76M	48.97M	48.65M

Currency in GBP

Tiziana Life Sciences Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing